Pfizer CEO psychs up investors for a rebate-free world under Trump

글 내용 전체보기

Sticker prices in drug ads just got closer with bipartisan backing in Senate

글 내용 전체보기

A slowing market—not new rivals—is hurting Pfizer’s star cancer med Ibrance, executives say

글 내용 전체보기

Sanofi and other drugmakers stockpile drugs in preparation for Brexit chaos

글 내용 전체보기

With Future on the Line, NewLink Genetics Restructures and Refocuses on IDO Inhibitors

글 내용 전체보기

Mulpleta FDA nod in hand, Shionogi must distinguish it from competitor Dova’s similar drug

글 내용 전체보기

Hop on the bus: AbbVie takes hepatitis C testing to veterans in co-campaign with American Legion

글 내용 전체보기

Mammoth Biosciences Closes on Series A Worth $23 Million

글 내용 전체보기

Novo Nordisk channels ’70s ‘Magic’ in first TV ad for blockbuster-in-waiting Ozempic

글 내용 전체보기

The top 5 vaccine companies by 2017 revenue

글 내용 전체보기

GE Healthcare And Lantheus Announce Start Of A Phase 3 Clinical Trial Of Flurpiridaz, An Investigational Agent Being Evaluated For The Detection Of Coronary Artery Disease

글 내용 전체보기

ReViral Closes $55 Million Series B to Advance RSV Treatment

글 내용 전체보기

Novartis licenses out unwanted GlaxoSmithKline cancer drugs to Chinese biotech

글 내용 전체보기

CAR-T player Cell Medica names Kite’s European chief as CEO

글 내용 전체보기

Oncorus poaches Moderna cancer executive Ted Ashburn as CEO

글 내용 전체보기

ReViral raises $55M to run midphase RSV clinical trials

글 내용 전체보기

Q2 Results: Bioprocessing Vendors Return to Double-Digit Growth

글 내용 전체보기

Amgen Breaks Ground on $160m Rhode Island Plant

글 내용 전체보기

Research on mutation ‘hotspots’ in DNA could lead to new insights on cancer risks

글 내용 전체보기

FDA Accepts File for Cladribine Tablets as Potential Treatment for Relapsing Forms of MS

글 내용 전체보기

Researchers predict cell conversion factors

글 내용 전체보기